265 related articles for article (PubMed ID: 21787829)
41. Immunization with live attenuated influenza viruses that express altered NS1 proteins results in potent and protective memory CD8+ T-cell responses.
Mueller SN; Langley WA; Carnero E; García-Sastre A; Ahmed R
J Virol; 2010 Feb; 84(4):1847-55. PubMed ID: 19939929
[TBL] [Abstract][Full Text] [Related]
42. A Vero-cell-adapted vaccine donor strain of influenza A virus generated by serial passages.
Hu W; Zhang H; Han Q; Li L; Chen Y; Xia N; Chen Z; Shu Y; Xu K; Sun B
Vaccine; 2015 Jan; 33(2):374-81. PubMed ID: 25448099
[TBL] [Abstract][Full Text] [Related]
43. Differences in Type I interferon response in human lung epithelial cells infected by highly pathogenic H5N1 and low pathogenic H11N1 avian influenza viruses.
Thube MM; Shil P; Kasbe R; Patil AA; Pawar SD; Mullick J
Virus Genes; 2018 Jun; 54(3):414-423. PubMed ID: 29574656
[TBL] [Abstract][Full Text] [Related]
44. [Preclinical studies of live intranasal H5N1 influenza vaccine with the deleted HS1 gene].
Romanovskaia-Roman'ko EA; Ferko B; Vyshemirskiĭ OI; Romanova IuR; Krenn B; Muster T; Grudinin MP; Lapin BA; Egorov AIu; Kiselev OI
Vopr Virusol; 2011; 56(6):19-22. PubMed ID: 22359944
[TBL] [Abstract][Full Text] [Related]
45. Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs.
Govorkova EA; Kodihalli S; Alymova IV; Fanget B; Webster RG
Dev Biol Stand; 1999; 98():39-51; discussion 73-4. PubMed ID: 10494958
[TBL] [Abstract][Full Text] [Related]
46. Influenza virus non-structural protein 1 (NS1) disrupts interferon signaling.
Jia D; Rahbar R; Chan RW; Lee SM; Chan MC; Wang BX; Baker DP; Sun B; Peiris JS; Nicholls JM; Fish EN
PLoS One; 2010 Nov; 5(11):e13927. PubMed ID: 21085662
[TBL] [Abstract][Full Text] [Related]
47. A Naturally Occurring Deletion in the Effector Domain of H5N1 Swine Influenza Virus Nonstructural Protein 1 Regulates Viral Fitness and Host Innate Immunity.
Wang J; Zeng Y; Xu S; Yang J; Wang W; Zhong B; Ge J; Yin L; Bu Z; Shu HB; Chen H; Lei CQ; Zhu Q
J Virol; 2018 Jun; 92(11):. PubMed ID: 29563291
[TBL] [Abstract][Full Text] [Related]
48. Rescue of influenza virus expressing GFP from the NS1 reading frame.
Kittel C; Sereinig S; Ferko B; Stasakova J; Romanova J; Wolkerstorfer A; Katinger H; Egorov A
Virology; 2004 Jun; 324(1):67-73. PubMed ID: 15183054
[TBL] [Abstract][Full Text] [Related]
49. Influenza B mutant viruses with truncated NS1 proteins grow efficiently in Vero cells and are immunogenic in mice.
Wressnigg N; Shurygina AP; Wolff T; Redlberger-Fritz M; Popow-Kraupp T; Muster T; Egorov A; Kittel C
J Gen Virol; 2009 Feb; 90(Pt 2):366-374. PubMed ID: 19141445
[TBL] [Abstract][Full Text] [Related]
50. Viral Subpopulation Screening Guides in Designing a High Interferon-Inducing Live Attenuated Influenza Vaccine by Targeting Rare Mutations in NS1 and PB2 Proteins.
Ghorbani A; Abundo MC; Ji H; Taylor KJM; Ngunjiri JM; Lee CW
J Virol; 2020 Dec; 95(2):. PubMed ID: 33115873
[TBL] [Abstract][Full Text] [Related]
51. Genetic analysis of influenza virus NS1 gene: a temperature-sensitive mutant shows defective formation of virus particles.
Garaigorta U; Falcón AM; Ortín J
J Virol; 2005 Dec; 79(24):15246-57. PubMed ID: 16306596
[TBL] [Abstract][Full Text] [Related]
52. Oncolytic effects of a novel influenza A virus expressing interleukin-15 from the NS reading frame.
van Rikxoort M; Michaelis M; Wolschek M; Muster T; Egorov A; Seipelt J; Doerr HW; Cinatl J
PLoS One; 2012; 7(5):e36506. PubMed ID: 22563505
[TBL] [Abstract][Full Text] [Related]
53. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems.
García-Sastre A; Egorov A; Matassov D; Brandt S; Levy DE; Durbin JE; Palese P; Muster T
Virology; 1998 Dec; 252(2):324-30. PubMed ID: 9878611
[TBL] [Abstract][Full Text] [Related]
54. Multiple anti-interferon actions of the influenza A virus NS1 protein.
Kochs G; García-Sastre A; Martínez-Sobrido L
J Virol; 2007 Jul; 81(13):7011-21. PubMed ID: 17442719
[TBL] [Abstract][Full Text] [Related]
55. NS1 protein of influenza A virus down-regulates apoptosis.
Zhirnov OP; Konakova TE; Wolff T; Klenk HD
J Virol; 2002 Feb; 76(4):1617-25. PubMed ID: 11799156
[TBL] [Abstract][Full Text] [Related]
56. Characterization of a novel mutation in NS1 protein of influenza A virus induced by a chemical substance for the attenuation of pathogenicity.
Sasaki K; Hayashi K; Lee JB; Kurosaki F; Hayashi T
PLoS One; 2015; 10(3):e0121205. PubMed ID: 25793397
[TBL] [Abstract][Full Text] [Related]
57. Effect of human activated NRAS on replication of delNS1 H5N1 influenza virus in MDCK cells.
Zhu J; Zhou H; Zou W; Jin M
Virol J; 2011 May; 8():240. PubMed ID: 21595878
[TBL] [Abstract][Full Text] [Related]
58. Alleles A and B of non-structural protein 1 of avian influenza A viruses differentially inhibit beta interferon production in human and mink lung cells.
Munir M; Zohari S; Metreveli G; Baule C; Belák S; Berg M
J Gen Virol; 2011 Sep; 92(Pt 9):2111-2121. PubMed ID: 21632557
[TBL] [Abstract][Full Text] [Related]
59. Trypsin promotes efficient influenza vaccine production in MDCK cells by interfering with the antiviral host response.
Seitz C; Isken B; Heynisch B; Rettkowski M; Frensing T; Reichl U
Appl Microbiol Biotechnol; 2012 Jan; 93(2):601-11. PubMed ID: 21915610
[TBL] [Abstract][Full Text] [Related]
60. Influenza A virus strains that circulate in humans differ in the ability of their NS1 proteins to block the activation of IRF3 and interferon-β transcription.
Kuo RL; Zhao C; Malur M; Krug RM
Virology; 2010 Dec; 408(2):146-58. PubMed ID: 20934196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
